Navigation Links
OpenQ is Awarded Prestigious Life Sciences Industry Award
Date:6/15/2009

OpenQ wins the 2009 Global Pharmaceutical CRM Growth Strategy Leadership of the Year presented by Frost & Sullivan

Charlottesville, VA, New York, NY and Paris, France (PRWEB) June 15, 2009 -- OpenQ, one of the industry leaders in KOL management solutions and MSL performance tools, announces that it has received the prestigious 2009 Global Pharmaceutical CRM Growth Strategy Leadership of the Year award, presented by Frost & Sullivan to the company that has demonstrated an exceptional growth strategy within the industry.

A recipient is chosen to receive the Frost & Sullivan Award for CRM Growth Strategy Leadership of the Year based on specific criteria. Through primary and secondary research methods, all companies' market revenues are tracked and those exhibiting significant growth are noted for their strategy implementation. Revenues are then compared year to year to monitor growth patterns. When a company consistently shows high growth rates, it is a candidate for the Frost & Sullivan Award Growth Strategy Leadership of the Year.

This accolade is given to the company that has bolstered their position in the market during the base year and whose strategy will have a profound and lasting impact on the market. The award criteria consist of the following:

 
  • Ability to grow in a saturated or maturing market
  • Implementing a unique sales strategy
  • Technological innovation and leadership
  • Discovering new venues for an established product
  • Effective Internet strategy
  • Strategic mergers, acquisitions, or joint ventures to penetrate new markets
  • Reorganization structured around growth strategy

About openQ:
OpenQ provides the integrated insights and software solutions to meet the critical compliance, KOL, content and speaker needs facing Life Science companies, from development stage through maturity. Achieving another year of exponential growth, openQ serves its customers from various locations across North America, South America, Europe and Asia. OpenQ's growing list of customers includes 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies. For more information, visit http://www.openq.com.

###

Read the full story at http://www.prweb.com/releases/2009/06/prweb2530554.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches
2. Proplant Awarded Qatar Project
3. Plexus Awarded Development Contract With QIAGEN
4. Enerkem GreenField Alberta Biofuels Awarded Permit to Build Worlds First Commercial Municipal Waste-to-Biofuels Facility
5. ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program
6. CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors
7. ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security
8. Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio
9. PCI Biotech-led Consortium Awarded EUR1.1 m Eurostars Grant for siRNA
10. Transgenomic Awarded Clinical Laboratory Certification in California
11. OLIGOMERIX Awarded NIH Grant to Develop Novel Biomarkers for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
OpenQ is Awarded Prestigious Life Sciences Industry Award
(Date:6/27/2016)... ... , ... Parallel 6 , the leading software as a service (SaaS) ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between ... Using the CONSULT module, patients and physicians can schedule a face to face virtual ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
Breaking Biology Technology:
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):